Therapy Areas: Autoimmune
8 July 2024 - Medicine company Eli Lilly and Company (NYSE: LLY) and biopharmaceutical company Morphic Holding Inc (NASDAQ: MORF) on Monday announced a definitive agreement for Lilly to acquire Morphi...
5 July 2024 - Biotech company BioSenic (Euronext Brussels/Paris:BIOS) announced on Friday that it has filed a continuation patent application in the United States to protect the use of arsenic trioxid...
2 July 2024 - Q32 Bio Inc. (Nasdaq: QTTB), a US-based clinical stage biotechnology company, announced on Monday that it is joining the Russell 3000 Index at the conclusion of the 2024 Russell Indexes ...
1 July 2024 - Clinical-stage biotech company Sareum Holdings plc (AIM: SAR) on Monday announced positive topline results from its Phase 1a trial of SDC-1801, a dual TYK2/JAK1 kinase inhibitor aimed at...
25 June 2024 - AI-enabled drug discovery and development company BenevolentAI (Euronext Amsterdam:BAI) announced on Tuesday that biopharmaceutical company AstraZeneca plc (STO:AZN) (LON:AZN) (Nasdaq:A...
14 June 2024 - UCB, a Belgium-based global biopharmaceutical company, announced on Thursday results from three studies supporting the value of CIMZIA(R) (certolizumab pegol), a PEGylated fragment crys...